glp 1 agonist liver disease The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis Emerging Role of GLP-1 Receptor
Description
& Brubaker, M
[DOI] [PMC free article] [PubMed] [Google Scholar] 69.FDA Approves Weight Management Drug for Patients Aged 12 and Older FDA
Dement Geriatr Cogn Disord
Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonist
6,7 Glucagon-like peptide-1 receptor agonists (GLP-1RAs), indicated for type 2 diabetes mellitus (T2DM) and weight loss, 7 have seen a 5-fold increase in their market share since 2020
